UCLA Samueli School Of Engineering

What UCLA Samueli School Of Engineering does

UCLA Samueli School of Engineering, officially the Henry Samueli School of Engineering and Applied Science, is a public engineering school within the University of California, Los Angeles. It educates approximately 491 students (288 undergraduate and 203 graduate) and houses multiple departments including Bioengineering, which operates with 45 core faculty and 70+ joint or affiliated appointments across 32 labs and centers in five named research thrust areas. The school serves undergraduate and graduate engineering students, postdoctoral researchers, and industrial and clinical partners who license or collaborate on its research output.

Its core research portfolio spans biomedical devices (magnetoelastic smart stent), cellular immunotherapies (CAR-iNKT cancer platform), photonic and signal-analysis technologies, and is expanding into semiconductors and fusion energy. Technology transfer flows through the UCLA Technology Development Group (TDG), with notable alumni-founded exits including Cytovale and ANEUVO (FDA-cleared devices) and Ouro Medicines (acquired by Gilead for $1.68 billion). The school's research combines engineering with the David Geffen School of Medicine to produce clinically translatable biomedical technologies.

The school's revenue model is academic and not commercial: it operates on a mix of state appropriations, tuition, federally funded and industry-sponsored research ($345 million in industry-sponsored research disclosed), licensing income ($460 million disclosed), philanthropy, and large programmatic grants such as the $125 million Semiconductor Hub and $8 million UC Fusion Energy Initiative. Customers in the industry-research sense include medical device and pharmaceutical firms (Edwards Lifesciences, Genentech, Amgen, Medtronic), semiconductor industry partners, and government agencies; learners and trainees function as the primary long-tail "customer base."

Name

UCLA Samueli School Of Engineering

Legal name

UCLA Henry Samueli School of Engineering and Applied Science

Website

https://bioeng.ucla.edu

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

51–100 employees

Short description

The UCLA Samueli School of Engineering is a public engineering school within the University of California that educates undergraduate and graduate students and conducts interdisciplinary research in bioengineering, semiconductors, and fusion energy, translating academic output into industry partnerships, licensed technologies, and alumni startups.

Ownership category

akta.pro rank

Product category

Engineering Education and Research

NAICS

Colleges, Universities, and Professional Schools (6113), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Engineering Services (8711), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Public Research Universities with Engineering/Polytechnic Emphasis (EDAHAAAD)

akta.pro secondary industry

Technical Universities with Computing, Data & AI Focus (EDAHAEAK)

Keywords

• Engineering education
• Biomedical research
• Graduate engineering programs
• Bioengineering research
• Academic research services

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Tuition and Fees: Public university receiving state funding and tuition revenue for undergraduate and graduate education programs.
2. Research Grants and Funding: Federal and state research grants including NIH, NSF, DOD funding. $8 million fusion energy initiative through UC system grants.
3. Industry Partnerships and Philanthropy: $125 million Semiconductor Hub combining philanthropic gifts and in-kind support from technology partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

UCLA Samueli School of Engineering is a public academic institution offering ABET-accredited undergraduate (B.S.) and graduate (M.S., Ph.D., Professional M.Eng.) bioengineering degree programs while conducting multidisciplinary research across five thrust areas: Biomedical Devices and Instrumentation, Molecular Cellular and Tissue Engineering, Biomedical Imaging, Biomedical Data Sciences, and NeuroEngineering. The school operates research centers including the California NanoSystems Institute and partners with industry on technology transfer, sponsored research, and large-scale initiatives such as the $125 million Semiconductor Hub.

Product overview

UCLA Samueli School of Engineering is an academic institution offering comprehensive educational programs and conducting cutting-edge research. The Bioengineering department provides ABET-accredited undergraduate and graduate degree programs (B.S., M.S., Ph.D., and Professional Master of Engineering) across five research thrust areas: Biomedical Devices and Instrumentation, Molecular Cellular and Tissue Engineering, Biomedical Imaging, Biomedical Data Sciences, and NeuroEngineering. The institution operates multiple research centers (Brain Research Institute, California NanoSystems Institute, CASIT, Crump Institute for Molecular Imaging, and others) and numerous research labs. Notable research technologies developed include the magnetoelastic smart stent for continuous blood flow monitoring, the implantable CAR-iNKT cell charging station for cancer immunotherapy, and tetrapod zinc oxide sunscreen formulations. The institution has also launched major research initiatives including a $125 million Semiconductor Hub in partnership with leading technology companies.

Differentiator

Problem solved

Functional benefit

Brands

• Bioengineering Institute of California (BIC): A University of California, Office of the President multicampus research unit that provides infrastructure to support bioengineering research across all ten UC campuses
• California NanoSystems Institute (CNSI)
• Bioengineering Department

Products and services

• Bioengineering B.S. Degree Program ABET-accredited undergraduate degree program providing fundamental scientific knowledge and engineering tools necessary for graduate study, professional schools, or industry employment. Includes tracks in Biomaterials and Regenerative Medicine and Biomedical Devices, with capstone design experience.
• Graduate Programs (M.S. and Ph.D.) in Bioengineering M.S. (Thesis, Capstone, and Comprehensive Examination tracks) and Ph.D. degree programs in Bioengineering across five research fields: Biomedical Devices and Instrumentation, Molecular Cellular and Tissue Engineering, Biomedical Imaging, Biomedical Data Sciences, and NeuroEngineering. Designed for students seeking advanced research training leading to academic, industry, or medical careers.
• Professional Master of Engineering Degree in Translational Medicine Professional master's degree program focused on translational medicine, preparing students for industry careers by bridging biomedical research and clinical application.

Quantifiable outcome

• Over 95% of UCLA Bioengineering undergraduates participate in research before graduation
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

16 partnerships are on record, tiered flagship, core and minor.

• BroadcomflagshipStrategic or Co-development Partner · 21 May 2026Founding partner in $125 million UCLA Samueli Semiconductor Hub for AI-powered chip research and workforce development over five-year initiative spanning chip design, software, manufacturing, equipment, and advanced materials.
• Applied MaterialsflagshipStrategic or Co-development Partner · 21 May 2026Founding partner in $125 million UCLA Samueli Semiconductor Hub for AI-powered chip research and workforce development over five-year initiative spanning chip design, software, manufacturing, equipment, and advanced materials.
• GlobalFoundriesflagshipStrategic or Co-development Partner · 21 May 2026Founding partner in $125 million UCLA Samueli Semiconductor Hub for AI-powered chip research and workforce development over five-year initiative spanning chip design, software, manufacturing, equipment, and advanced materials.
• MetaflagshipStrategic or Co-development Partner · 21 May 2026Founding partner in $125 million UCLA Samueli Semiconductor Hub for AI-powered chip research and workforce development over five-year initiative spanning chip design, software, manufacturing, equipment, and advanced materials.
• SynopsysflagshipStrategic or Co-development Partner · 21 May 2026Founding partner in $125 million UCLA Samueli Semiconductor Hub for AI-powered chip research and workforce development over five-year initiative spanning chip design, software, manufacturing, equipment, and advanced materials.
• Los Alamos National LaboratorycoreStrategic or Co-development Partner · 10 February 2026Collaboration in California Center for Fusion Energy as part of UC's $8 million fusion energy initiative, with UCLA leading computational simulation for fusion materials.
• Lawrence Livermore National LaboratorycoreStrategic or Co-development Partner · 10 February 2026Collaboration in California Center for Fusion Energy as part of UC's $8 million fusion energy initiative, with UCLA leading computational simulation for fusion materials.
• Edwards LifesciencescoreStrategic or Co-development PartnerIndustry Advisory Board member providing guidance on curriculum and research direction. Hengchu Cao, Ph.D. serves as Director, Engineering representative.
• GenentechcoreStrategic or Co-development PartnerIndustry Advisory Board member. Ken Hamilton, Ph.D. serves as Director of Process Engineering; Jin Jin, Ph.D. serves as Executive Director and Global Head of Modeling & Simulation.
• AmgencoreStrategic or Co-development PartnerIndustry Advisory Board member. Scott Gibson, Ph.D. serves as Director, Systems Engineering and Risk Management.
• MedtroniccoreStrategic or Co-development PartnerIndustry Advisory Board member. Michael E. Miller, Ph.D. serves as Senior Principal Scientist.
• Varian (Siemens Healthineers)coreStrategic or Co-development PartnerIndustry Advisory Board member. Zoe Deng, Ph.D. serves as Manager, Strategy and Corporate Development.
• Cerevel TherapeuticsminorStrategic or Co-development PartnerIndustry Advisory Board member. Nirmal Keshava, Ph.D. serves as Vice President of Data Analytics and Innovation Science.
• XencorminorStrategic or Co-development PartnerIndustry Advisory Board member. John R. Desjarlais, Ph.D. serves as Chief Scientific Officer.
• KinamedminorStrategic or Co-development PartnerIndustry Advisory Board member. William Pratt serves as VP Operations and Director of Creative Design.
• ACatecholminorStrategic or Co-development PartnerIndustry Advisory Board member. Kollbe Ahn, Ph.D. serves as Chief Executive Officer.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• UC San Diego Department of Bioengineering: UC San Diego Bioengineering is another UC-system peer with strong biomedical devices, tissue engineering, and imaging research; it competes with UCLA for industry partnerships, NIH funding, and bioengineering graduate applicants in the California ecosystem.
• MIT Department of Biological Engineering: MIT Biological Engineering is a peer public-university bioengineering department with similar graduate programs, multidisciplinary research model, and strong industry translation record — a direct competitor for faculty talent, NIH funding, and graduate students.
• Duke University Biomedical Engineering: Duke BME is a peer research-university bioengineering department with similar biomedical thrust areas and medical-school co-location; it competes with UCLA for graduate students, NIH grants, and faculty recruits in biomedical devices and imaging.
• Stanford University School of Engineering (Bioengineering): Stanford Bioengineering is a directly comparable department within a top-tier U.S. research university, offering BS, MS, and PhD programs with similar biomedical thrust areas (devices, imaging, computational bio) and significant industry partnership activity in Silicon Valley.
• UC Berkeley Department of Bioengineering: Berkeley Bioengineering is a sibling UC-system department with comparable scope (biomedical devices, imaging, cellular engineering), shared UC regulatory environment, and overlapping faculty networks — the closest structural peer within the same university system.
• Georgia Tech / Emory Biomedical Engineering: The joint Georgia Tech / Emory BME program is a peer public-university bioengineering department with similar scope across devices, imaging, and cellular engineering, and a comparable industry translation record through ATDC and other tech-transfer channels.
• Johns Hopkins Department of Biomedical Engineering: JHU Biomedical Engineering is consistently a top-ranked U.S. bioengineering program with co-located medical school, comparable research thrust areas, and strong NIH funding capture — directly comparable in mission and competitive positioning.
• Caltech Division of Engineering and Applied Science: Caltech's engineering division hosts bioengineering-related research at a comparable scale of output-per-faculty; while smaller than UCLA, it competes directly for top-tier faculty and breakthrough biomedical publications.
• Carnegie Mellon Biomedical Engineering: Carnegie Mellon BME is a peer private-research-university bioengineering department with comparable engineering rigor, biomedical thrust areas, and industry translation record — competing for faculty and graduate students in biomedical devices and computation.

Regional players

• Caltech / UCLA partnership programs via CNSI: The California NanoSystems Institute (CNSI) is a joint UCLA/UCSB research institute focused on information, biomedical, and manufacturing technologies at the nanoscale — directly overlapping UCLA Samueli's biomedical nanotechnology and bioengineering research areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BioEngUCLA
• Facebookfacebook.com/BioEngUCLA
• LinkedInlinkedin.com/company/bioengucla
• Instagraminstagram.com/uclabioengineering

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UCLA Samueli School Of Engineering